Valeant Pharmaceuticals' Bridgewater location receives warning letter from FDA
Valeant announced the company's Bridgewater, New Jersey location received a Warning Letter from the FDA relating to an inspection in June 2014 of the Company's records with regards to Sculptra Aesthetic injectable, which was divested to Galderma in July 2014. September 30, 2014